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Abstract 
Purpose: To assess the effect of the crude methanol leaf extracts of Tulbaghia violacea William Henry 
Harvey (Alliaceae) on blood pressure (BP) and heart rate in ageing normotensive Wistar Kyoto rats 
(WKY), and compare the results obtained with those for adult spontaneously hypertensive rats (SHR).  
Methods: T. violacea (5 – 150 mg/kg) and/or vehicle (dimethylsulfoxide and normal saline) were 
respectively and randomly administered intravenously to groups of ageing (15 months) WKY and adult 
(< 5 months) SHR, weighing 380 - 470 and 280 - 320 g, respectively. BP and heart rate (HR) were 
measured via a pressure transducer connecting the femoral artery and Powerlab equipment.  
Results: T. violacea significantly and dose-dependently reduced systolic BP, diastolic BP, mean arterial 
pressure (MAP) and HR in both strains of rats. No statistically significant differences were however 
observed when the changes in BP and HR in the two rats strains were compared.  
Conclusion: T. violacea was effective in reducing BP and HR in both age-induced and spontaneously 
hypertensive rats. 
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Treatment of hypertension (HTN) has been one 
of the major successes of medicine in the past 
half-century [1,2]. However, the number of 
people with uncontrolled blood pressure is 
increasing, despite therapeutic advances [3]. 
Consequently, the prevalence of HTN is still on 
the rise in developing countries [4] and worldwide 
[3]. As a result of better management of both 
communicable and non-communicable diseases, 
the global population of the elderly is increasing, 
a trend that has been predicted to continue in the 
coming decades [3,5]. Therefore, the incidence 
and prevalence of HTN, as well as clinical and 
subclinical cardiovascular disease (CVD) in 
general, are expected to rise [3]. Hypertension is 
associated with considerable morbidity and an 
increased risk of CVD, stroke, decreased quality 
of life, and mortality in the elderly [1-3]. 
Furthermore, ageing and HTN play critical roles 
in both cardiovascular (CV) and cerebrovascular 
complications [2,3]. 
 
Tulbaghia violacea Harv. (Alliaceae) is common 
throughout Africa, with the highest concentration 
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in Southern Africa, where it is widely used as 
herbal remedy for various complaints, including 
HTN [6,7]. T. violacea has been suggested to 
have similar secondary metabolites and 
biological activities as garlic since they belong to 
the same plant family [6,7], and for these 
reasons, there has been a recent increase in the 
number of studies aimed at exploring and/ or 
confirming the therapeutic potential of T. violacea 
on the CV system [8-12].  
 
The direct and indirect costs of HTN are high 
[4,13], and the incidence of HTN is relatively high 
among the elderly. Also, the elderly are largely 
excluded from many clinical trials, as they belong 
to the upper age limits and/or do not present with 
age-specific results [5,14]. A couple of studies 
have investigated the effect of T. violacea on 
different strains of rats, including the adult Wistar 
rats [9], the spontaneously hypertensive rat 
(SHR) [11,12] and the Dahl salt-sensitive rats 
(DSS) [8,10,15]. The inhibition of the angiotensin 
converting enzyme (ACE) [9,11] and the β1 
adrenoceptors [12]; the reduction in the 
expression of angiotensin II type 1a (AT1a) 
mRNA [8], and levels of aldosterone in plasma 
[12]; and increases in diuresis and natriuresis  
[8,10] are some of the mechanisms that have 
been suggested to elicit the effects observed.  
 
Therefore, the present study assessed the effect 
of the crude methanol leaf extracts of T. violacea 
on blood pressure (BP) and heart rate in ageing 
normotensive Wistar Kyoto rats (WKY), and 







Fresh plants were purchased from the New Plant 
Nursery, George, South Africa in August and 
September, 2008; identified by a taxonomist at 
the University of the Western Cape (UWC), 
Bellville; and deposited at the herbarium at the 
UWC, with voucher numbers 6955 and 6956. 
 
Plant extraction 
To obtain the crude methanol leaf extract (MLE) 
of the plant, 2.4 kg of fresh plants were weighed, 
oven-dried, boiled in methanol in the Soxhlet 
apparatus. Excess solvent was removed from the 
resulting extract with a rotavapor and freeze-
drying, and the direct extract stored in a brown 
bottle in a -4 ºC freezer. The final dried extract 
was 76.6 g or 3.2 % of the original weight of the 




Healthy male WKY and SHR were obtained from 
the Animal Unit of the University of Cape Town, 
South Africa. The WKY weighed 380 - 470 g and 
aged just over 15 months, while the SHR 
weighed 280 - 320 g and aged less than 5 
months. All rats were kept in the Animal house, 
School of Pharmacy, University of the Western 
Cape; and given water and normal rat pellet ad 
libitum. The room temperature was kept at 24 ºC, 
with a 12:12 h light-dark cycle.  From literature, 
the median lifespan of the WKY is 21.5 months 
[16,17]. Therefore, 15 month old WKY were used 
in the present study. This is an age that is slightly 
older than those stated for aging groups in 




Drops of dimethylsulfoxide (Merck Chemicals, 
South Africa) were used to dissolve T. violacea, 
and the resultant paste made up to the required 
dilution using 0.9 % saline. 
 
In vivo experiments 
 
The effects of different doses of the methanol 
leaf extracts (MLE) of T. violacea (5–150 mg/kg) 
on both anaesthetized WKY and SH rats were 
determined using the method previously 
described [12]. The femoral artery of the rats 
were cannulated to measure BP and HR, while 
the jugular vein were cannulated for intravenous 
infusion of T. violacea.  The randomized dose-
response experiments (DRE) for MLE of T. 
violacea (5–150 mg/kg) were carried out using 8 




The paired and/or unpaired Student’s T test was 
used to calculate statistical significance (p < 
0.05) between values obtained at baseline with 
that obtained after infusing the dose of the 
extract. It was also used to compare the changes 
in BP and/or HR observed in the WKY with those 




The methodology and ethics adhered to in this 
study were approved by the Ethics Committee of 
the University of the Western Cape, with a 
registration number of 09/7/35. All experimental 
procedures used in the study were conducted in 
accordance with the guidelines provided by the 
European Community guidelines (EEC Directive 
of 1986; 86/609/EEC). 
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The ageing WKY rats used in this study had a 
body weight ranging from 380 - 470 g and were 
over 15 months old. In the WKY, T. violacea (150 
mg/kg) significantly (p < 0.05) and dose –
dependently decreased SBP, DBP and MAP 
values (66.83 ± 10.84, 31.33 ± 7.79 and 44.00 ± 
8.48 mmHg respectively; when compared to their 
respective values at baseline (139.25 ± 8.71, 
95.00 ± 6.81 and 110.38 ± 7.44 mmHg) (Figures 
1 to 3). This equates to 54.73 ± 4.36 %, 69.83 ± 
7.79 % and 63.04 ± 6.05 % reduction in SBP, 
DBP and MAP respectively with the highest dose 
(Table 1). T. violacea (150 mg/kg) also 
significantly (p < 0.05) and dose –dependently 
decreased HR values obtained (250.00 ± 9.81 
bpm) when compared to the value at baseline 
(379.38 ± 8.03 bpm) (Figure 4), i.e, a 33.72 ± 
1.03 % reduction in HR with the highest dose 
(Table 1). 
 
In the SHR, T. violacea (150 mg/kg) significantly 
(p < 0.05) and dose–dependently decreased the 
SBP, DBP and MAP values obtained (117.96 ± 
7.98, 73.06 ± 7.18 and 88.14 ± 7.17 mmHg 
respectively) when compared to their respective 
values at baseline (199.97 ± 5.17, 147.68 ± 4.63 
and 165.30 ± 4.55 mmHg) (Figures 1 to  3). This 
equates to 42.38 ± 3.68 %, 51.67 ± 4.33 % and 
47.91 ± 3.82 % reduction in SBP, DBP and MAP 
respectively at the highest dose (Table 1). T. 
violacea (150 mg/kg) also significantly (p < 0.05) 
and dose–dependently decreased HR values 
obtained (309.71 ± 20.15 bpm) when compared 
to the value at baseline (389.44 ± 17.31 bpm) 
(Figure 4), i.e, a 20.82 ± 1.96 % reduction in HR 
at the highest dose (Table 1).  
 
The percentage changes (%∆) in BP and HR 
observed at the different MLE doses were similar 
between the two rat strains (Figures 1 to 4). 
 
    Table 1: Baseline biologic parameters in WKY and SHR 
 
 AGE WEIGHT SBP DBP MAP HR M g mmHg bpm 
WKY 15 421.6 ± 14.9 139.3 ± 8.7 95.0 ± 6.8 110.4 ± 7.4 379.4 ± 8.0 
SHR 5 317. 9 ± 4.4* 200.0 ± 5.2* 147.7 ± 4.6* 165.3 ± 4.6* 389.4 ± 17.3 
    * Statistical significance. m = months. g = grams. bpm = beats per minute 
 
 
Figure 1: Effect of T. violacea (5 - 150 mg/kg) on SBP in WKY and SHR. Values are presented as mean ± SEM. 
★ indicates statistical significance 
 
 
Figure 2: Effect of T. violacea (5 - 150 mg/kg) on DBP in WKY and SHR. Values are presented as mean ± SEM. 
★ indicates statistical significance 
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Figure 3: Effect of T. violacea (5 - 150 mg/kg) on MAP in WKY and SHR. Values are presented as mean ± SEM. 
★ indicates statistical significance 
 
 
Figure 4: Effect of T. violacea (5 - 150 mg/kg) on HR in WKY and SHR. Values are presented as mean ± SEM; ★ 




The age of the WKY rats (15 months) used in 
this study is equivalent to 45 years and above in 
humans [20,21]. The difference in basal HR 
between the ageing WKY and the adult SHR was 
not significant. However, the ageing WKY had 
significantly lower BP, and significantly higher 
body weight as compared to the adult SHR.  The 
baseline SBP of the ageing rats used in this 
study was significantly higher than the normal 
value of 120 ± 14 mmHg as seen in adult (5 
months) normotensive rats, while the SBP of the 
SHR used in the study was also higher than the 
normal value for normotensive rats, but within the 
normal range for hypertensive rats  [17,22].  
 
Rats of different strains and age were used in the 
study to compare the effect of the crude MLE of 
T. violacea on old age - related increase in  BP, 
with spontaneous HTN [19,23]. T. violacea 
significantly and dose-dependently reduced the 
SBP, DBP, MAP and HR in both WKY (Figure 1) 
and SHR (Figure 2), with the percentage 
changes (%∆) in both BP and HR being similar 
between the two strains of. The results obtained 
in the ageing WKY is consistent with that 
obtained by Ramesar et al [9] in adult Wistar 
rats, while that obtained in the SHR corroborates 
previous results in SHRs [11,12] and Dahl salt 
sensitive rats [8,10,15]. 
 
The mechanisms implicated in the pathogenesis 
of CVD include alterations in the renin 
angiotensin aldosterone system (RAAS) [2], the 
autonomic nervous system [2,24], the reactive 
oxygen species [25], and thrombosis [25]. 
Similarly, T. violacea has been reported to inhibit 
ACE [9,11] and the expression of AT1a mRNA 
[8]; reduce aldosterone levels in plasma [12], and 
consequently increase diuresis and natriuresis  
[8,10] in rats. It has also been found to stimulate 
the muscarinic receptors [12], block β1 
adrenoceptors [12], and improve antioxidant 
activity [6]. Although the specific mechanisms by 
which T. violacea reduced BP and HR in the 
ageing WKY and SHR were not investigated in 
the current study, we propose that some of the 
mechanism previously mentioned, with other rats 
of different ages and genetic make-up [6,8-
12,15], would have contributed to the 
antihypertensive effect observed. 
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Crude MLE of T. violacea reduces BP and HR in 
ageing normotensive WKY rats and in adult 
spontaneously hypertensive rats. No significant 
differences were observed with the BP and HR-
lowering effect, despite the differences in the 
pathology of high blood pressure in the two 
strains used. Thus, T. violacea may not only be 
able to reduce BP and HR in rats, but may also 
be useful in the management of HTN in both 
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